• HyperFusion high-fidelity DNA polymerase Workflows

  2026-08-20

  Build accurate PCR workflows for C. elegans neurodegeneration studies, from pathway genotyping to long-amplicon cloning and targeted sequencing. HyperFusion™ combines proofreading accuracy, inhibitor tolerance, and strong performance on GC-rich or difficult templates with minimal enzyme input.

• SCP4 Dephosphorylates H3T3 to Protect Chromosomes

  2026-08-20

  The reference study identifies SCP4 as a nuclear phosphatase that removes the mitotic H3T3 phosphate and helps control chromosomal passenger complex recruitment. Cellular, chromosome-segregation, and mouse-zygote evidence connects abnormal SCP4 activity with mitotic errors, lagging chromosomes, and aneuploidy.

• Palomid 529 (P529) for ESCC Signaling Studies

  2026-08-19

  Palomid 529 (P529) is a practical dual mTORC1/mTORC2 probe for connecting PI3K/Akt pathway activity with ESCC metastasis, cisplatin resistance, angiogenesis, and radiotherapy response. This workflow-oriented guide covers formulation, dose design, pathway readouts, combination experiments, and troubleshooting.

• Balsalazide for Active Ulcerative Colitis: Evidence Review

  2026-08-19

  The 2009 review by Wiggins and Rajapakse examines balsalazide as a colon-targeted 5-aminosalicylate prodrug for inducing remission in active ulcerative colitis. Its central clinical message is that bacterial azoreduction enables sustained colonic delivery of 5-ASA, with evidence of faster and more frequent symptomatic remission than mesalamine and a broadly comparable safety profile.

• FXR Phase Separation Clusters β-Coronavirus Organelles

  2026-08-18

  Li et al. identify fragile X–related proteins as host factors that use liquid–liquid phase separation to cluster coronavirus double-membrane vesicles, creating a spatial environment that supports viral RNA production and translation. The study connects condensate biology with replication-organelle architecture and provides a mechanistic framework for interpreting host-factor perturbation and imaging experiments.

• Faropenem sodium in Reliable Cell Assays

  2026-08-18

  Faropenem sodium (SKU C8712) can help researchers standardize antimicrobial conditions around cell viability, proliferation, and cytotoxicity assays without confusing bacterial inhibition with mammalian-cell toxicity. This scenario-driven guide covers mechanism, solvent compatibility, transporter context, assay controls, and practical supplier-selection criteria.

• Rhodamine 123 (chloride): Reliable Efflux Assays

  2026-08-17

  A scenario-based guide to using Rhodamine 123 (chloride), SKU C3140, for P-glycoprotein efflux, transporter-function, and cytotoxicity workflows. It explains assay design, solvent and storage controls, interpretation limits, and practical vendor-selection criteria for reproducible laboratory use.

• IEM 1460: AMPA Receptor Blocker Workflows

  2026-08-16

  IEM 1460 provides a selective way to isolate AMPA receptor contributions in excitotoxicity, synaptic transmission, and neuroprotection experiments. This guide translates recent glutamate-receptor research into practical assay design, formulation, controls, and troubleshooting strategies.

• IBDV VP3 Disrupts IRF7 Antiviral Signaling

  2026-08-15

  The reference study identifies IBDV VP3 as a viral antagonist of chicken IRF7, linking VP3 expression to proteasome-associated IRF7 degradation, reduced IFN-β signaling, and enhanced viral replication. Its combination of infection models, IRF7 gain- and loss-of-function experiments, protein-stability analysis, and VP3 interaction studies provides a mechanistic framework for understanding IBDV immune evasion.

• ATG4B Nuclear Translocation and DNA Repair in AML

  2026-08-15

  The reference study identifies energy deficiency-induced nuclear translocation of ATG4B as a molecular link between metabolic stress, impaired DNA repair, and acute myeloid leukemia progression. Its results position the ATG4B–PRMT1–MRE11 axis as a mechanistic and potentially actionable framework for studying genomic instability in AML.

• SIS3: A Smad3 Inhibitor for Causal Assays

  2026-08-14

  SIS3 is a selective Smad3 inhibitor for dissecting TGF-β signaling, fibrosis, and disease-associated transcription. This article explains how to use SIS3 as a causal assay tool, including its relevance to super-enhancer-driven lung adenocarcinoma research.

• Live-Dead Cell Staining Kit I: Practical Guide

  2026-08-14

  This scenario-driven guide explains how Live-Dead Cell Staining Kit I (Calcein AM/PI), SKU K2247, can improve mammalian cell viability and cytotoxicity workflows. It covers assay principles, compatibility, protocol optimization, image interpretation, and practical vendor-selection criteria without overstating unsupported performance claims.

• (+)-Bicuculline: Practical Protocol Guide

  2026-08-13

  (+)-Bicuculline is a research-use GABAA receptor antagonist for controlled studies of inhibitory neurotransmission, GABAergic signaling pathway activity, and related neuronal signaling responses. This dossier-based guide addresses solubility, storage, controls, and interpretation limits; the compound is not intended for diagnostic, clinical, or therapeutic use.

• HNF4A-AS1, Lipid Reprogramming, and Sorafenib Resistance

  2026-08-13

  This Theranostics study identifies the liver-enriched lncRNA HNF4A-AS1 as a regulator of sorafenib sensitivity in hepatocellular carcinoma. Its central innovation is the linkage of HNF4A-AS1 to METTL3-dependent m6A modification, DECR1 mRNA turnover, polyunsaturated fatty acid abundance, and ferroptosis.

• Citron OGD2, Iron, and Canker Resistance

  2026-08-12

  The reference study identifies CmOGD2 as an iron- and ROS-linked regulator of citron resistance to citrus canker caused by Xanthomonas citri subsp. citri. Its key advance is the discovery of a feedback circuit involving CmENO2 and CmZAT10.1, together with evidence that the pathogen effector pthA4 disrupts this circuit to reshape host defense.

446 records 7/30 page Previous Next First page 上5页 678910 下5页 Last page